Questioning drugs to treat "female orgasmic disorder"

Printer-friendly version

A new CBC Radio podcast highlights the arguments for and against the use of testosterone to treat a condition that is being called “female orgasmic disorder”. Trials of this hormone on women are now being carried out in Canada.

Critics say this disorder does not exist, and that is a marketing ploy by drug companies.

Listen for Barbara Mintzes’ critique of the trials. Mintzes, a drug assessment specialist, is co-author of the book, Sex, Lies, and Pharmaceuticals: How Drug Companies Plan to Profit from Female Sexual Dysfunction. 

Listen to the CBC podcast, originally broadcast on the Current on November 21, 2012

Read the CBC story.

Learn more about the medicalization of women’s sexuality in a webinar CWHN sponsored featuring Barbara Mintzes.